NewsPosted on 15 May 2013 The Board of Photonz Corporation is delighted to announce the appointment of Dr James Campbell to the role of CEO as part of a staged transition that sees Dr Greg Collier assume the CEO role of the ASX-listed biotech company Invion Limited. Posted on 20 March 2013 Dr Hywel Griffiths, Chief Scientific Officer for Photonz Corp. was named the 2013 Young Biotechnologist of the Year by NZBIO at an award ceremony Tuesday evening. Posted on 9 November 2012 AUCKLAND via ALGAE WORLD ASIA CONFERENCE SINGAPORE – 8 November 2012 – Talks are underway involving potential partners of Photonz Corporation as the company is finalising its process for manufacturing eicosapentaenoic acid (EPA) by fermentation of micro-algae.Click to expand list Posted on 15 May 2013 The Board of Photonz Corporation is delighted to announce the appointment of Dr James Campbell to the role of CEO as part of a staged transition that sees Dr Greg Collier assume the CEO role of the ASX-listed biotech company Invion Limited. Posted on 20 March 2013 Dr Hywel Griffiths, Chief Scientific Officer for Photonz Corp. was named the 2013 Young Biotechnologist of the Year by NZBIO at an award ceremony Tuesday evening. Posted on 9 November 2012 AUCKLAND via ALGAE WORLD ASIA CONFERENCE SINGAPORE – 8 November 2012 – Talks are underway involving potential partners of Photonz Corporation as the company is finalising its process for manufacturing eicosapentaenoic acid (EPA) by fermentation of micro-algae.Posted on 6 November 2012 New Zealand based Photonz Corporation would soon enter a new phase of being a commercial-ready producer of eicosapentaenoic acid (EPA) from fermented algae, a major biotech summit in Australia has been told.Posted on 4 September 2012Hywel Griffiths, Chief Scientific Officer of Photonz Corporation Ltd was featured on radio station bFM.Posted on Nov. 21 2011Photonz Corporation has achieved a major milestone on the path to commercially manufacturing, by fermentation, the high-value omega-3 fatty acid, EPA...Posted on Sep. 21 2011Biotech company Photonz Corporation has entered into a development agreement with Novasep, a world-class provider of purification technology...Posted on Apr. 6, 2011Under the agreement Separex, under a license of Stanipharm, will develop a manufacturing process, scalable to industrial volumes, to concentrate the Omega-3 fatty acid, eicosapentaenoic acid (EPA), which Photonz extracts from fermented microalgal biomass...Posted on Mar. 28, 2011Awarded under the TechNZ programme, the grant will enable the biotech company to undertake work that will, when completed, allow it to commence commercial production of the omega-3 fatty acid eicosapentaenoic acid (EPA) from marine micro-algae....Click to Shrink list
|
|
Posted on 15 May 2013 The Board of Photonz Corporation is delighted to announce the appointment of Dr James Campbell to the role of CEO as part of a staged transition that sees Dr Greg Collier assume the CEO role of the ASX-listed biotech company Invion Limited. Posted on 20 March 2013 Dr Hywel Griffiths, Chief Scientific Officer for Photonz Corp. was named the 2013 Young Biotechnologist of the Year by NZBIO at an award ceremony Tuesday evening. Posted on 9 November 2012 AUCKLAND via ALGAE WORLD ASIA CONFERENCE SINGAPORE – 8 November 2012 – Talks are underway involving potential partners of Photonz Corporation as the company is finalising its process for manufacturing eicosapentaenoic acid (EPA) by fermentation of micro-algae. Posted on 6 November 2012 New Zealand based Photonz Corporation would soon enter a new phase of being a commercial-ready producer of eicosapentaenoic acid (EPA) from fermented algae, a major biotech summit in Australia has been told. Posted on 4 September 2012Hywel Griffiths, Chief Scientific Officer of Photonz Corporation Ltd was featured on radio station bFM. |
|
